10x Genomics (TXG) Acquisitions (2021 - 2022)

10x Genomics (TXG) posted Acquisitions of $2.5 million for Q4 2022, up 66.67% sequentially from $1.5 million in Q3 2022.

10x Genomics (TXG) Acquisitions (2021 - 2022) Analysis & Trends

10x Genomics has reported Acquisitions for 2 years, with the latest figure at $2.5 million in Q4 2022.

Quarterly Acquisitions changed N/A year-over-year to $2.5 million in Q4 2022, while the trailing twelve-month figure through Dec 2023 was $4.0 million (changed 0.0% YoY) and the FY2022 annual result came in at $4.0 million, down 26.62% from the prior year.
Acquisitions grew to $2.5 million in Q4 2022 per TXG's latest filing, from $1.5 million in the prior quarter.
Over five years, Acquisitions peaked at $5.5 million in Q1 2021 and troughed at $1.5 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	75.48 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	-
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	-
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	-
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	-
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	-
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-
10	Privia Health	2.78 Bn	2.42 Bn	-	-

Download Data